Cargando…
Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The “Opt-Out” Process
PURPOSE: In order to meet a clinical need for better pathways to access genetic testing for ovarian cancer patients, we implemented and reviewed an opt-out referral process for genetic consultation whereby a referral is automatically sent to genetics following a pathological diagnosis of HGSC. METHO...
Autores principales: | McGee, Jacob, Peart, Teresa M., Foley, Norine, Bertrand, Monique, Prefontaine, Michel, Sugimoto, Akira, Ettler, Helen, Welch, Stephen, Panabaker, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466895/ https://www.ncbi.nlm.nih.gov/pubmed/31061661 http://dx.doi.org/10.1155/2019/6029097 |
Ejemplares similares
-
Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario
por: McGee, Jacob, et al.
Publicado: (2017) -
Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids
por: Peart, Teresa, et al.
Publicado: (2015) -
Inclusion of Residual Tissue in Biobanks: Opt-In or Opt-Out?
por: Giesbertz, Noor A. A., et al.
Publicado: (2012) -
Assessing Global Organ Donation Policies: Opt-In vs Opt-Out
por: Etheredge, Harriet Rosanne
Publicado: (2021) -
Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)